Sanofi and Bristol gain EU support for wider approval of Plavix

11/21/2010 | Reuters

Bristol-Myers Squibb and Sanofi-Aventis have obtained the European Medicines Agency's endorsement to use anti-clotting drug Plavix for the prevention of thromboembolic and atherothrombotic events in certain adults with atrial fibrillation.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC